Drug profile · INN
bosentan hydrate
TRACLEER (PEDIATRIC DISPERSIBLE TABLETS)
bosentan hydrate (TRACLEER (PEDIATRIC DISPERSIBLE TABLETS)) is a endothelin receptor, et-a/et-b antagonist.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — bosentan hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
bosentan hydrate (TRACLEER (PEDIATRIC DISPERSIBLE TABLETS)) is a endothelin receptor, et-a/et-b antagonist.
Key facts
INN bosentan hydrate
Brand TRACLEER (PEDIATRIC DISPERSIBLE TABLETS)
Mechanism Endothelin receptor, ET-A/ET-B antagonist
Target Endothelin receptor, ET-A/ET-B
Mechanism of action
Endothelin receptor, ET-A/ET-B antagonist
Primary target: Endothelin receptor, ET-A/ET-B
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is bosentan hydrate?
bosentan hydrate (TRACLEER (PEDIATRIC DISPERSIBLE TABLETS)) is a endothelin receptor, et-a/et-b antagonist.
What is the brand name for bosentan hydrate?
TRACLEER (PEDIATRIC DISPERSIBLE TABLETS) is a marketed brand name for bosentan hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.